Page 2 - B Pfizer News Today

Johnson & Johnson is suspending sales forecasts for its COVID-19 vaccine only a few months after saying the shot could bring in as much as $3.5 billion this year.

Pfizer said Tuesday it reached a deal with the humanitarian-aid branch of the U.N. to supply 4 million courses of its pills for COVID-19 to low- and middle-income countries, likely making them the first significant treatments available in poorer parts of the world.

Drugmaker Moderna asked the Food and Drug Administration on Thursday to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults.

Drugmaker Moderna asked the Food and Drug Administration on Thursday to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults.

Drugmaker Pfizer is expected to request authorization this week for an additional COVID-19 booster dose for seniors, according to a person familiar with the matter.

Drugmaker Pfizer is expected to request authorization this week for an additional COVID-19 booster dose for seniors, according to a person familiar with the matter.

The CEO of Pfizer said on Sunday that Americans may be required to get yearly booster shots to keep the coronavirus pandemic from resurging.

Drugmaker Pfizer said Monday it will wind down clinical trials in Russia while allowing its medicines to continue to flow into the country for compassionate reasons, using any proceeds for humanitarian assistance in Ukraine.

The CEO of Pfizer said on Sunday that Americans may be required to get yearly booster shots to keep the coronavirus pandemic from resurging.

The federal government needs to look strategically at how they spend taxpayer cash on medical technology. They should consider the efficient allocation of medicine and safety when setting priorities. We have come a long way since an extra vaccine was tossed in the trash and medical professionals learned there was massive destruction of unused vaccines for no good reason.